• Register
  • Login
  • Subscribe
  • Contact Us

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

USARFP notice for Bioengineering Partnerships with Industry (U01 Clinical Trial Optional). The reference ID of the tender is 64125004 and it is closing on 07 Jan 2025.

Tender Details

  • Country: USA
  • Summary: Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
  • UST Ref No: 64125004
  • Deadline: 07 Jan 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: PAR-22-123
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Tender are invited for Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    CFDA Number : 93.286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health93.394 -- Cancer Detection and Diagnosis Research93.395 -- Cancer Treatment Research93.866 -- Aging Research93.867 -- Vision Research
    Cost Sharing or Matching Requirement : No
    Closing Date for Applications: Jan 07, 2025
    Posted Date : Mar 08, 2022
    Description: This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Bioengineering Partnerships with Industry (U01 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 64125004 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-07.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

USARFP Features

USARFP Features

Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting USARFP !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from USA in your email inbox.

  Chat with us